Skip to main content
锦好医疗 logo

锦好医疗 — Investor Relations & Filings

Ticker · 920925 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2022-09-07 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920925

About 锦好医疗

https://www.jinghao.cn/

Jinghao Medical specializes in the research, development, and manufacturing of hearing aids and home medical electronic products. The company's core portfolio includes digital and analog hearing aids, medical nebulizers, and electronic blood pressure monitors. It focuses on providing hearing health solutions by integrating advanced digital signal processing technology into its devices. Jinghao Medical operates extensively in the global market, offering original design manufacturing (ODM) and original equipment manufacturing (OEM) services to international partners. The organization emphasizes technological innovation and maintains rigorous quality management systems to comply with international medical device standards. Its primary objective is to deliver accessible, high-performance medical equipment designed to improve the quality of life for users with hearing loss and other chronic health conditions.

Recent filings

Filing Released Lang Actions
关于申请银行授信暨资产抵押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Huizhou Jin Hao Medical Technology Co., Ltd. regarding the application for bank credit and asset mortgage. It details the company's plan to use certain properties as collateral to apply for a credit line from a bank. The document includes information about the board meeting approving the proposal and mentions that the proposal will be submitted to the shareholders' meeting for approval. There are no financial statements, earnings data, or detailed financial analysis present. The document is focused on financing activity related to bank credit and asset mortgage, which fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or a certification. Therefore, the appropriate classification is CAP with high confidence.
2022-09-07 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Huizhou JingHao Medical Technology Co., Ltd. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting system, shareholder meetings, and other governance-related provisions. It references relevant laws and regulations such as the Company Law of the People's Republic of China and securities regulations. The content is a comprehensive governance document outlining the internal rules, shareholder rights, board structure, and procedures for meetings and decision-making. It is not a financial report, earnings release, or announcement but a governance framework document. Therefore, the appropriate classification is Governance Information (CGR).
2022-08-21 Chinese
2022年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the company's third extraordinary general meeting of shareholders in 2022. It details the meeting date, attendance, agenda items, voting results, and legal compliance statements. The content focuses on shareholder meeting decisions, including capital increase and amendments to company bylaws, with no financial statements or earnings data presented. The document is a formal announcement of shareholder meeting resolutions rather than a full report or financial disclosure. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting results, confirming this classification with high confidence.
2022-08-21 Chinese
2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告摘要" which translates to "Half-Year Report Summary" for the year 2022. It contains detailed financial data such as total assets, net profit, earnings per share, and other financial metrics for the half-year period. It also includes business descriptions, shareholder information, and notes on new subsidiaries and stock incentive plans. The document length is 5466 characters, which is sufficient to contain substantive financial data and analysis. The content is consistent with a comprehensive interim or quarterly financial report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-21 Chinese
募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a public stock issuance by 惠州市锦好医疗科技股份有限公司. It includes specifics on the amount raised, usage of funds, bank accounts holding the funds, compliance with regulatory approvals, and the status of investment projects funded by the raised capital. The document references regulatory approvals from the China Securities Regulatory Commission and includes audit verification of fund receipt. It also discusses the use of idle funds for cash management products and confirms no changes in the use of raised funds. The content is focused on the actual use and management of capital raised, which aligns with a Capital/Financing Update rather than a general regulatory filing or announcement. The document length is about 4966 characters, which is sufficient to contain substantive financial and usage data, not just an announcement or certification. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2022-08-21 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "半年度报告" which translates to "Half-Year Report" or "Interim Report" for the period January 1, 2022 to June 30, 2022. It contains detailed financial data including income, profit, assets, liabilities, and operational highlights. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It includes comprehensive financial statements, management discussion, risk disclosures, and business overview. The presence of actual financial data and analysis for a period shorter than a full fiscal year confirms it is an Interim / Quarterly Report. Therefore, the correct classification is IR (Interim / Quarterly Report). H1 2022
2022-08-21 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.